European cost-effectiveness study of uPA/PAI-1 biomarkers to guide adjuvant chemotherapy decisions in breast cancer

Sophie Marguet, Chafika Mazouni, Bram L. T. Ramaekers, Ariane Dunant, Ronald Kates, Volker R. Jacobs, Manuela A. Joore, Nadia Harbeck, Julia Bonastre

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)168-179
JournalEuropean Journal of Cancer
Publication statusPublished - Aug 2016


  • Breast cancer
  • Adjuvant chemotherapy
  • Cost effectiveness
  • uPA/PAI-1
  • Quality of life

Cite this